IL1B and intestinal neoplasm: IL-1β appears to be dispensable for eradicating intestinal tumours because genetic ablation of type-I IL-1 receptor in hCEA-Tg/ApcMin/+ mice did not compromise the antitumour efficacy of PsV (Supplementary Fig. 7a).